Registration to BioCity Symposium is open until 11 August 2022. BioCity Symposium is one of the most important meetings in Turku region for researchers working in the fields of bio- and molecular medicine. This year the event is arranged together with InFLAMES Flagship with title Solution is in Immunity.
This year BioCity Student Symposium titled Students are the Solution is arranged on-site by PhD researchers from The University of Turku and Abo Akademi University together with BioCity Turku and InFLAMES Flagship in Cave theatre - Visitor and Innovation Centre Joki, 24th August 2022.
InFLAMES (Innovation Ecosystem based on the Immune System) is a Finnish research flagship that aims at identifying novel drug targets using the most modern technological platforms and finding novel diagnostic tools to identify the patients benefitting from personalised therapies.
Turku PET Centre opens a call for grant applications for scientific research in radiopharmaceutical chemistry. The grant is for research in preclinical development of new radiopharmaceuticals for positron emission tomography (PET).
The University of Turku and the Turku University Central Hospital (TYKS) have signed a cooperation agreement on the establishment of the Turku Brain & Mind regional network. The network promotes brain health research and cooperation in Southwest Finland. The regional networks of the Neurocenter Finland have been in operation since late 2021.
InFLAMES (Innovation Ecosystem based on the Immune System) is a Finnish research flagship that aims at identifying novel drug targets using the most modern technological platforms and finding novel diagnostic tools to identify the patients benefitting from personalised therapies.
This year BioCity Symposium is arranged on-site in Mauno Conference Centre, BioCity, together with InFLAMES Research Flagship 25–26 August 2022, with the title Solution is in Immunity. Registration is now open until 11 August 2022.
BioCity Turku is an umbrella organization supporting and coordinating research on life sciences and molecular medicine in University of Turku and Åbo Akademi University. BioCity Turku research programs strengthen the multidisciplinary and interdisciplinary research collaboration within the Turku campus. BioCity Turku asks for proposals for new research programs for 2022-2026.
Obesity risk factors of family background are associated with changes in the brain function, finds a study conducted at the Finnish Turku PET Centre. The results show that the function of neural networks regulating satiety and appetite is altered already before a person develops obesity.
Diabetes is a risk factor for cognitive decline. In a study of the University of Turku and Finnish Institute for Health and Welfare, the researchers observed that already a higher two-hour glucose level in the glucose tolerance test predicts worse performance in a test measuring episodic memory after ten years. Decline in episodic memory is one of the first symptoms of Alzheimer’s disease.